The next installment of our Meet the VCs webinar series, we’re pleased to have had Kyle Welborn of Cultivation Capital and Alex Bondar of Acre Venture Partners join us. Kyle will start us off with an overview of the 2025 AgTech area investment and exit data, observations on the various market sectors within AgTech, and…
Here is the first in a series of webinars to introduce you to VCs who often invest in startups arising from academic research. Our introductory “Meet the VCs” session will highlight Mission BioCapital and Portal Innovations, both of which are early-stage life science investors that also offer state-of-the-art shared lab facilities in multiple locations. Our…
In January of 2020, the U.S. Federal Government issued final rules fully implementing the new powers granted to the Committee on Foreign Investment in the United States (CFIUS). Effective February 13, 2020, the Committee started to exercise its expanded ability to review the national security implications of more foreign investments – in particular companies with ‘novel or advanced technology’ including biotechnology, artificial intelligence, robotics, quantum computing, and advanced materials. New mandatory filing rules are now in place, and the Committee’s new enforcement team – charged with finding unfiled cases within CFIUS’s jurisdiction – is now bringing in far more cases than ever before.
In 2014 venture funding in healthcare IT shattered records, surpassing $4.1 billion, followed by an equally impressive performance in 2015 with $4.5 billion invested in the sector. While investment in digital healthcare cooled slightly in 2016 compared to previous record highs, investment in the sector remains significant with $4.3 billion invested in 2016. It’s a diverse, emerging sector with a barrage of startups competing in a broad marketplace to improve healthcare delivery as the nation’s $3 trillion healthcare delivery system gradually transitions from volume-based to value-based care.